Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Solomon McCown & Cence was a Boston-based strategic communications, public affairs, crisis management, government relations, and digital marketing firm. The agency originated as Solomon McCown & Company in 2003 and was renamed Solomon McCown & Cence in 2020 after Daniel F. Cence became CEO, owner, and managing partner. In 2022, the firm merged with Murphy Donoghue Partners and began operating under the new brand Issues Management Group. While the company served clients in healthcare and other regulated sectors, it was not itself a biotech, pharma, or healthcare operating company. It is best understood as a professional services firm focused on communications and advocacy rather than drug development or healthcare delivery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Solomon McCown & Cence.